Bambino Gesù e INFN insieme per la ricerca e lo sviluppo di radiofarmaci oncologici

19 December 2024

On 19 December, Bambino Gesù Pediatric Hospital and INFN signed a five-year collaboration agreement to enhance the study and development of radiopharmaceuticals, to improve oncological radiotherapy techniques and to contribute to the optimization of increasingly precise and personalized treatments. In particular, the goal is to develop new-generation PET radiopharmaceuticals, capable of offering superior diagnostic precision, perfecting radiometabolic therapies and personalizing radiotherapy. Biokinetic and biodistribution analyses will also be conducted to monitor how radiopharmaceuticals are distributed and act in the body over time. One of the techniques involves the use of wearable devices, such as T-shirts or pajamas, equipped with dosimeters for continuous and less invasive monitoring, to contribute to improving the quality of life of patients.

Agreement signing photograph
You might also be interested in
rendering Einstein Telescope

Signed an inter-agency agreement for the promotion of Sos Enattos candidacy

MUR, Lazio Region, and INFN agreement signing

MUR, Lazio region and INFN together for the future of plasma accelerators

AEgIS experiment photograph

CERN: first laser cooling of a cloud of positronium atoms

Cosinus Cryostat Installation LNGS 2024 6

At LNGS the inauguration of COSINUS project

NA62 experiment

CERN: the NA62 experiment observes an extremely rare process

INFN_Lab2Go_2024

The 9th edition of INFN LAB2GO project gets underway